Cargando…

Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases

Complications after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) result in impaired short- and long-term outcomes. However, financial consequences of complications after CRS and HIPEC in a European health care setting are unknown. This study aims to assess the co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simkens, Geert A., Rovers, Koen P., van Oudheusden, Thijs R., Nienhuijs, Simon W., Rutten, Harm J., de Hingh, Ignace H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	7100
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882423/ https://www.ncbi.nlm.nih.gov/pubmed/29517660 http://dx.doi.org/10.1097/MD.0000000000010042

Ejemplares similares

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
por: Simkens, Geert A, et al.
Publicado: (2017)

Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC
por: Simkens, Geert A, et al.
Publicado: (2021)

Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery
por: Simkens, Geert A., et al.
Publicado: (2016)

Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
por: Sluiter, Nina R., et al.
Publicado: (2018)

Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial
por: Bakkers, C., et al.
Publicado: (2023)

Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study
por: Hentzen, Judith E. K. R., et al.
Publicado: (2019)

The Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) versus Conventional Surgery on Patient-Reported Outcomes: A Comparative Cohort Study between the CAIRO6 Trial and the PROCORE Study
por: Bakkers, Checca, et al.
Publicado: (2023)

Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
por: Spiliotis, J. D., et al.
Publicado: (2014)

Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis
por: Fernández-Candela, Alba, et al.
Publicado: (2021)

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)
por: Rovers, Koen P., et al.
Publicado: (2019)

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol
por: Kuijpers, Anke M. J., et al.
Publicado: (2013)

Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study
por: Liu, Gang, et al.
Publicado: (2017)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Intra-Operative Radiotherapy for Patients with Locally Advanced or Locally Recurrent Rectal Cancer and Peritoneal Metastases
por: van de Vlasakker, Vincent C. J., et al.
Publicado: (2023)

Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis
por: Cardi, Maurizio, et al.
Publicado: (2015)

Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Jayakrishnan, Thejus T, et al.
Publicado: (2014)

Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease
por: Khan, Hamza, et al.
Publicado: (2022)

Postoperative Peritonitis Without An Underlying Digestive Fistula After Complete Cytoreductive Surgery Plus HIPEC
por: Honoré, Charles, et al.
Publicado: (2013)

Practice patterns, attitudes, and knowledge among physicians regarding cytoreductive surgery and HIPEC for patients with peritoneal metastases
por: Bernaiche, Tyler, et al.
Publicado: (2018)

Peritoneal metastases of rare carcinomas treated with cytoreductive surgery and HIPEC – A single center case series
por: Brandl, Andreas, et al.
Publicado: (2017)

Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study
por: Rijken, Anouk, et al.
Publicado: (2023)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes
por: Rosa, Fausto, et al.
Publicado: (2021)

2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer
por: Hübner, Martin, et al.
Publicado: (2023)

Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands
por: Burg, Lara, et al.
Publicado: (2020)

Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis
por: Yurttas, Can, et al.
Publicado: (2022)

Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review
por: Yap, Daniel Ren Yi, et al.
Publicado: (2021)

Management of Inguinal Involvement of Peritoneal Surface Malignancies by Cytoreduction and HIPEC with Inguinal Perfusion
por: Shachar, Yair, et al.
Publicado: (2015)

Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
por: Marrelli, Daniele, et al.
Publicado: (2022)

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: Clinical outcomes at 2 tertiary referral centers in Korea
por: Park, Eun Jung, et al.
Publicado: (2017)

ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases
por: Sluiter, Nina R., et al.
Publicado: (2018)

Survival of large volume recurrent endometrial cancer with peritoneal metastases treated by cytoreductive surgery, HIPEC and EPIC. Report of a case
por: Sugarbaker, Paul H.
Publicado: (2021)

Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence
por: Pasqual, Enrico Maria, et al.
Publicado: (2023)

Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition?
por: Swain, David R., et al.
Publicado: (2018)

Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Kartik, Akash, et al.
Publicado: (2023)

Acute kidney injury increases the rate of major morbidities in cytoreductive surgery and HIPEC()
por: Naffouje, Samer A., et al.
Publicado: (2018)

Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases
por: Enblad, Malin, et al.
Publicado: (2019)

Postoperative delirium in patients undergoing surgery for bone metastases
por: Hindiskere, Suraj, et al.
Publicado: (2020)

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
por: Vassos, Nikolaos, et al.
Publicado: (2016)

ASO Author Reflections: Patient-Reported Outcomes of the CAIRO6 Phase II Trial
por: Bakkers, Checca, et al.
Publicado: (2023)

Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC)
por: Lurvink, Robin J., et al.
Publicado: (2021)

Cytoreductive Surgery (CRS) and Hyperthermic IntraPeritoneal Chemotherapy (HIPEC): don’t throw the baby out with the bathwater
por: Königsrainer, Alfred, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_47g793ns4vqnolc2gldf2605u0